JIMENEZ FREDDY A. (SVP & General Counsel) sold 11.9% of their position (4.17K shares) of CELLDEX THERAPEUTICS, INC. on the open market
Open‑market sale worth $121.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/8/2025ACC: 0001838114-25-000007
Officer· SVP & General Counsel
Since Jan 2021
-4.17K
Net shares
Net seller
$121.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.17K
Price / share
$29.09
Trade value
$121.21K
% of position
11.9%
12/4/2025
34.96K→30.80K
Total
Net shares
−4.17K
Net value
-$121.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/4/2025 | S · Sale | −4.17K | $29.09 | $121.21K | 11.9% | 34.96K | 30.80K |
| Total | −4.17K | -$121.21K | ||||||
Derivative Transactions0
No derivative transactions reported